Jean-Guy Goulet
Directeur Général chez Juno Pharmaceuticals Corp.
Profil
Jean-Guy Goulet is currently the Chief Executive Officer at Juno Pharmaceuticals Corp.
He is also the Vice Chairman at The Canadian Generic Pharmaceutical Association.
Additionally, he holds positions as a Director at 10379085 Canada, Inc., Biosimilars Canada, and Pharmascience, Inc. Previously, he served as a Director at LYRtech, Inc.
Postes actifs de Jean-Guy Goulet
| Sociétés | Poste | Début |
|---|---|---|
The Canadian Generic Pharmaceutical Association
 The Canadian Generic Pharmaceutical Association Pharmaceuticals: GenericHealth Technology The Canadian Generic Pharmaceutical Association provides generic prescription medicines and active pharmaceutical ingredients. The company was founded in 1984 and is headquartered in Toronto, Canada. | Directeur/Membre du Conseil | 05/10/2017 |
10379085 Canada, Inc.
 10379085 Canada, Inc. Financial ConglomeratesFinance 10379085 Canada, Inc. is an investment holding Canadian company founded in 2017. The private company is based in Montréal, Canada. | Directeur/Membre du Conseil | - |
Pharmascience, Inc.
 Pharmascience, Inc. Pharmaceuticals: MajorHealth Technology Pharmascience, Inc. manufactures and distributes generic and drug products. It offers liquids, tablets, capsules, suppositories, powders, and ophthalmic. The company was founded by Morris Goodman and Ted S. Wise in 1983 and is headquartered in Montr?al, Canada. | Directeur des opérations | 01/05/2017 |
Biosimilars Canada
 Biosimilars Canada Miscellaneous Commercial ServicesCommercial Services Biosimilars Canada is a division of the Canadian Generic Pharmaceutical Association that provides leadership in educating Canadian stakeholders about the safety and efficacy of biosimilar medicines. Biosimilars Canada is based in Toronto, Canada. The member companies of Biosimilars Canada are involved in the development and marketing of biosimilar medicines. The organization advocates for policies that support the timely approval, reimbursement, market acceptance, and expanded use of biosimilar medicines. Health Canada evaluates all the information provided to confirm that the biosimilar and the reference biologic drug are similar and that there are no clinically meaningful differences in safety and efficacy between them. | Directeur/Membre du Conseil | - |
Juno Pharmaceuticals Corp.
 Juno Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Juno Pharmaceuticals Corp. specializes in bringing complex and high-value generic and biosimilar products to the Canadian market. The company is based in Mississauga, Canada, and has subsidiaries in Canada. The Juno management team possesses decades of pharmaceutical industry experience and has a track record of driving strategic growth through the identification of niche products and disciplined construction of robust product pipelines. Juno licenses and acquires specialized pharmaceutical products that have limited competitors and inherent barriers to market entry. The Canadian company was founded in 2019, and Mark Mantel has been the CEO of the company since 2022. | Directeur Général | 07/05/2024 |
Anciens postes connus de Jean-Guy Goulet
| Sociétés | Poste | Fin |
|---|---|---|
LYRtech, Inc.
 LYRtech, Inc. Packaged SoftwareTechnology Services LYRtech, Inc. develops and manufactures advanced digital signal processing solutions for companies worldwide. It provides vital technologies to network and wireless communications, audio & video processing and other electronic systems in all fields of technology. The firm offers a full range of DSP-FPGA development platforms and also designs prototyping and manufacturing of electronic products. It markets a line of products and software in the fields of digital signal processing based platforms and electro optics. The company was founded by Louis N. Bélanger and Louis Chouinard in 1983 and is headquartered in Quebec City, Canada. | Directeur/Membre du Conseil | 23/01/2008 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
LYRtech, Inc.
LYRtech, Inc. Packaged SoftwareTechnology Services LYRtech, Inc. develops and manufactures advanced digital signal processing solutions for companies worldwide. It provides vital technologies to network and wireless communications, audio & video processing and other electronic systems in all fields of technology. The firm offers a full range of DSP-FPGA development platforms and also designs prototyping and manufacturing of electronic products. It markets a line of products and software in the fields of digital signal processing based platforms and electro optics. The company was founded by Louis N. Bélanger and Louis Chouinard in 1983 and is headquartered in Quebec City, Canada. | Technology Services |
The Canadian Generic Pharmaceutical Association
The Canadian Generic Pharmaceutical Association Pharmaceuticals: GenericHealth Technology The Canadian Generic Pharmaceutical Association provides generic prescription medicines and active pharmaceutical ingredients. The company was founded in 1984 and is headquartered in Toronto, Canada. | Health Technology |
10379085 Canada, Inc.
10379085 Canada, Inc. Financial ConglomeratesFinance 10379085 Canada, Inc. is an investment holding Canadian company founded in 2017. The private company is based in Montréal, Canada. | Finance |
Pharmascience, Inc.
Pharmascience, Inc. Pharmaceuticals: MajorHealth Technology Pharmascience, Inc. manufactures and distributes generic and drug products. It offers liquids, tablets, capsules, suppositories, powders, and ophthalmic. The company was founded by Morris Goodman and Ted S. Wise in 1983 and is headquartered in Montr?al, Canada. | Health Technology |
Biosimilars Canada
Biosimilars Canada Miscellaneous Commercial ServicesCommercial Services Biosimilars Canada is a division of the Canadian Generic Pharmaceutical Association that provides leadership in educating Canadian stakeholders about the safety and efficacy of biosimilar medicines. Biosimilars Canada is based in Toronto, Canada. The member companies of Biosimilars Canada are involved in the development and marketing of biosimilar medicines. The organization advocates for policies that support the timely approval, reimbursement, market acceptance, and expanded use of biosimilar medicines. Health Canada evaluates all the information provided to confirm that the biosimilar and the reference biologic drug are similar and that there are no clinically meaningful differences in safety and efficacy between them. | Commercial Services |
Juno Pharmaceuticals Corp.
Juno Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Juno Pharmaceuticals Corp. specializes in bringing complex and high-value generic and biosimilar products to the Canadian market. The company is based in Mississauga, Canada, and has subsidiaries in Canada. The Juno management team possesses decades of pharmaceutical industry experience and has a track record of driving strategic growth through the identification of niche products and disciplined construction of robust product pipelines. Juno licenses and acquires specialized pharmaceutical products that have limited competitors and inherent barriers to market entry. The Canadian company was founded in 2019, and Mark Mantel has been the CEO of the company since 2022. | Health Technology |
